Appt Health Secures Funding to Improve Cervical and Lung Cancer Screening Uptake
We’re delighted to announce that Appt Health, in collaboration with Imperial College London and Prova Health, has been awarded funding through the NHS Cancer Programme Innovation Open Call, supported by SBRI Healthcare and the Accelerated Access Collaborative, to advance our work on improving Lung and Cervical cancer screening uptake, in particular for low uptake groups, across the NHS.
This funding will support the implementation and evaluation of a patient-centred approach to patient engagement with the aim of increasing participation in lung and cervical cancer screening, particularly among low uptake and high-risk populations. Appt Health’s platform combines behavioural science, inclusive co-design, and automated patient engagement to better engage patients who are often missed by traditional approaches.
Working nationwide across seven Cancer Alliances (West Yorkshire and Harrogate, East Midlands, East of England, North East London, Royal Marsden Partners, South East London, and Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliances), the project will explore how personalised, inclusive digital communication can drive earlier diagnosis and more equitable access to life-saving screening services.
Our partnership with the Institute of Global Health Innovation at Imperial College London will bring a rigorous impact evaluation to the work, whilst Prova Health will add an economic and process evaluation. This comprehensive evaluation will ensure that we generate meaningful, scalable insights that can support national screening programmes.
We’re excited to collaborate with our NHS partners to transform how patients are invited to participate in preventive care — and ultimately, to help close the gap in cancer outcomes.
Disclaimer: This work was commissioned and funded by the NHS Cancer Programme, with the support of SBRI Healthcare and the NHS Accelerated Access Collaborative. The views expressed in the publication are those of the author(s) and not necessarily those of the NHS Cancer Programme or its stakeholders.
